Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers. - Bialucha CU; Collins SD; Li X; Saxena P; Zhang X; Dürr C; Lafont B; Prieur P; Shim Y; Mosher R; Lee D; Ostrom L; et al. (Cancer discovery, 2017)